Article info
Original article
A feasibility study on the effects of Triton X-100 for the in vitro inactivation of Ebola virus on haematological assays
- Correspondence to Dr Alex Gatt, Department of Haematology, Mater Dei Hospital, Tal-Qroqq, Msida, Malta; MSD2090 alexander.a.gatt{at}gov.mt
Citation
A feasibility study on the effects of Triton X-100 for the in vitro inactivation of Ebola virus on haematological assays
Publication history
- Received August 10, 2015
- Revised November 11, 2015
- Accepted November 12, 2015
- First published December 15, 2015.
Online issue publication
June 20, 2016
Article Versions
- Previous version (15 December 2015).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/